BELVIQ is a new anti-obesity drug, which appeared on retail market in 2012

BELVIQ is an innovative drug, which precise mechanism of action has not been studied yet. It is reliably known that BELVIQ stimulates some types of receptors in the brain, thereby increasing satiety and helping to reduce the food consumption.

Arena Pharmaceuticals is the developer of Belviq weight loss drug. Japan pharmaceutical company Eisai is the international distributer of Belviq. The USA is one of the few countries, where Belviq pills are already available.

In May 2013, Arena Pharmaceuticals withdrew its application on getting the trade license for Belviq in the EU. By the time the application was withdrawn, members of the Committee for Medicinal Products for Human Use (CHMP) shared their opinion, saying that Belviq’s potential risks are greater than its benefits for the treatment of pre-obese and obese patients.



Final decision on approval and disapproval in EU was not made. It is possible that examination of post-marketing research of Belviq, CHMP will approve this drug for obesity treatment. So, in 2001-2015, Belviq will be available in European countries.

If you want to buy Belviq drug, but it is not sold in your town, you can order Belviq on online pharmacy. Before buying Belviq online, make sure this weight loss drug can be delivered to the region you live in. If you decide to buy Belviq but have never taken this appetite suppressant before, learn the key information on this drug.

The Pharmaceutical Form

Arena Pharmaceuticals produces Belviq film-coated tablets, containing 10mg of the active ingredient Lorcaserin. Apart from the anorexigenic agent Lorcaserin, every Belviq tablet contains pharmaceutical excipients:

Arena Pharmaceuticals produces BELVIQ film-coated tablets, containing 10mg of the active ingredient Lorcaserin.

Apart every BELVIQ contains pharmaceutical excipients:

  1. Silicified microcrystalline cellulose
  2. Magnesium stearate
  3. Polyethylene glycol
  4. Hydroxypropyl cellulose
  5. FD&C Blue #2 aluminum lake
  6. Croscarmellose sodium
  7. Talc
  8. Colloidal silicon dioxide
  9. Titanium dioxide
  10. Polyvinyl alcohol

You may find blisters with 10 BELVIQ tablets and plastic bottles with 100 BELVIQ tablets at a retail sale. Marketing status of Belviq 10mg tablets in the USA – RX Only.

  • Color and shape of BELVIQ tablets: blue, biconvex and round.
  • Marking on BELVIQ tablets: “10” (on one side), “A” (on the other side).

The Uniqueness of BELVIQ Tablets

Belviq differs from other anorexic drugs by that it acts mostly on serotonergic nervous system. Many other anorexic drugs (including Phentermine, Diethylpropion or Benzphetamine) act directly on the noradrenergic and dopaminergic nervous systems.

Due to a selective impact on the serotonergic receptors of the brain, BELVIQ does not cause any cardiovascular side effects. Therefore, BELVIQ tablets are prescribed to patients, whose obesity is complicated by cardiovascular pathologies.

Other drugs providing anorexigenic effect (such as Phentermine) are not recommended for obesity treatment in patients with a history of cardiovascular diseases.

Efficiency of BELVIQ

The results of clinical studies have proven the safety and efficiency of Belviq. According to these results:

Over 47% of patients, using Belviq within 12 months managed to lose at least 5% of their body weight

Over 22% of patients, using Belviq within 12 months, managed to reduce their body mass by 10% and more

Belviq tablets should be used only in combination with hypocaloric, balanced diet and physical loads. The FDA approved Belviq 10mg tablets for:

  • Obesity treatment in overweight patients with BMI 30 and higher
  • Reduction of the body weight in pre-obese patients with BMI 27 to 29 (inclusive)

Maximum recommended treatment duration for Belviq is two years. Belviq trials exceeding 2 years have not been conducted. Drug interactions between Belviq and other OTC and RX weight loss drugs are unknown.

Obesity statistics (% of adult population)

United States 34%
Mexico 30%
New Zealand 27%
Australia 25%
United Kingdom 25%
Canada 24%
Ireland 23%

Potential Risks of BELVIQ

Just as any other serotonergic drug, Belviq may cause serotonin syndrome. The symptoms of serotonin syndrome are:

  • Autonomic dysfunction (high heart rate, fluctuating blood pressure, high temperature)
  • Gastrointestinal disorders (nausea, diarrhea, vomiting, constipation)
  • Psychiatric side effects (agitation, confusion, hallucinations, tremor, incoordination, hyperreflexia and hypomania)

If any symptoms of serotonin syndrome occur, a patient should stop taking Belviq and consult a doctor. To relieve the symptoms of serotonin syndrome, the doctor can prescribe Diazepam or other antipsychotic drug of benzodiazepines group.


To buy BELVIQ weight loss drug you need a prescription. Only patients of 18 years old and older can get the prescription for BELVIQ tablets. The doctor can prescribe BELVIQ tablets only after an obese patient undergoes a medical examination. When BELVIQ tablets a prescribed for a long-term anti-obesity therapy, a patient should undergo a medical examination every 3-6 months.